{"nctId":"NCT00920621","briefTitle":"Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)","startDateStruct":{"date":"2009-09"},"conditions":["Asthma"],"count":876,"armGroups":[{"label":"Vitamin D treatment","type":"EXPERIMENTAL","interventionNames":["Dietary Supplement: Vitamin D 3 cholecalciferol","Dietary Supplement: Vitamin D3"]},{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Vitamin D3"]}],"interventions":[{"name":"Vitamin D 3 cholecalciferol","otherNames":["vitamin D","vitamin D3","cholecalciferol"]},{"name":"Vitamin D3","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Personal history of asthma, eczema, allergic rhinitis or a history of asthma, eczema, allergic rhinitis in the biological father of the child\n* Gestational age between 10 and 18 weeks at the time of randomization\n* Maternal age between 18 and 39 years\n* Not a current smoker\n* English or Spanish speaking\n* Intent to participate for the full 4 years (through Pregnancy and then until the 3rd birthday of the child)\n\nExclusion Criteria:\n\n* Not meeting inclusion criteria\n* Gestational age greater than 18 weeks\n* Presence of chronic medical conditions\n* Taking vitamin D supplements containing more than 2000 IU/day of vitamin D3\n* Multiple gestation pregnancy (twins, triplets)\n* Pregnancy achieved by assisted reproduction techniques (e.g., IUI, IVF)","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"39 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Asthma or Recurrent Wheeze in First 3 Years of Life","description":"Parental report of physician diagnosis of asthma or occurrence of recurrent wheeze in the child's first 3 years of life ascertained from questionnaires administered every 3 months.\n\n\\*For some variables the \"negative\" count incorporates \"negative and indeterminate.\"","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98","spread":null},{"groupId":"OG001","value":"120","spread":null}]},{"measurements":[{"groupId":"OG000","value":"307","spread":null},{"groupId":"OG001","value":"281","spread":null}]}]}]},{"type":"PRIMARY","title":"Achieved Maternal 25(OH)D Level of â‰¥ 30 ng/mL at Third Trimester Sampling.","description":"Maternal serum 25-hydroxyvitamin D measurement at third trimester during pregnancy","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"289","spread":null},{"groupId":"OG001","value":"133","spread":null}]},{"measurements":[{"groupId":"OG000","value":"97","spread":null},{"groupId":"OG001","value":"258","spread":null}]}]}]},{"type":"SECONDARY","title":"Child Positive-specific IgE Tests From Blood Collection at 3 Year Visit.","description":"Child positive-specific IgE tests from blood collection at 3 year visit.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"414","spread":null},{"groupId":"OG001","value":"452","spread":null}]}]}]},{"type":"SECONDARY","title":"Child Serum 25-hydroxyvitamin D Measurement From Blood Collection at 1 Year Visit.","description":"Child serum 25-hydroxyvitamin D measurement from blood collection at 1 year visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.3","spread":"9.2"},{"groupId":"OG001","value":"30.1","spread":"10.8"}]}]}]},{"type":"SECONDARY","title":"Parental Report of Physician Diagnosed Eczema (With Rash) in the Child's First 3 Years of Life.","description":"Parental report of physician diagnosis of eczema with rash in typical distribution in the child's first 3 years of life ascertained from questionnaires administered every 3 months.\n\n\\*For some variables the \"negative\" count incorporates \"negative and indeterminate.\"","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"89","spread":null}]},{"measurements":[{"groupId":"OG000","value":"322","spread":null},{"groupId":"OG001","value":"312","spread":null}]}]}]},{"type":"SECONDARY","title":"Parental Report of Physician Diagnosis of Lower Respiratory Tract Infection in the Child's First 3 Years of Life.","description":"Parental report of physician diagnosis of lower respiratory tract infection (LRI) in the child's first 3 years of life. LRI defined as physician diagnosed bronchitis, bronchiolitis, croup, or pneumonia ascertained from questionnaires administered every 3 months.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"222","spread":null},{"groupId":"OG001","value":"276","spread":null}]}]}]},{"type":"SECONDARY","title":"Child Serum 25-hydroxyvitamin D Measurement From Blood Collection at 3 Year Visit.","description":"Child serum 25-hydroxyvitamin D measurement from blood collection at 3 year visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.3","spread":"10.4"},{"groupId":"OG001","value":"21.5","spread":"8.5"}]}]}]},{"type":"SECONDARY","title":"Any Allergic Sensitization in the Child's First 3 Years of Life.","description":"Any allergic sensitization in the child's first 3 years of life.\n\n\\*For some variables the \"negative\" count incorporates \"negative and indeterminate.\"","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"146","spread":null},{"groupId":"OG001","value":"144","spread":null}]},{"measurements":[{"groupId":"OG000","value":"132","spread":null},{"groupId":"OG001","value":"117","spread":null}]}]}]},{"type":"SECONDARY","title":"Mass Spec Vitamin D Value From Cord Blood at Delivery","description":"Mass Spec Vitamin D value from cord blood at delivery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28.2","spread":"12.4"},{"groupId":"OG001","value":"19.1","spread":"9.7"}]}]}]},{"type":"SECONDARY","title":"Sphingolipid Profile","description":"Mass spec measured relative abundance of five metabolites of the sphingolipid metabolism pathway in plasma samples extracted at the year one visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.32","spread":"0.10"},{"groupId":"OG001","value":"0.32","spread":"0.10"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":"0.20"},{"groupId":"OG001","value":"0.31","spread":"0.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":"0.13"},{"groupId":"OG001","value":"0.34","spread":"0.13"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.34","spread":"0.17"},{"groupId":"OG001","value":"0.33","spread":"0.17"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.06"},{"groupId":"OG001","value":"0.32","spread":"0.06"}]}]}]},{"type":"SECONDARY","title":"Sphingolipid Profile","description":"Mass spec measured relative abundance of five metabolites of the sphingolipid metabolism pathway in plasma samples extracted at the year three visit.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.34","spread":"0.12"},{"groupId":"OG001","value":"0.32","spread":"0.12"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.39","spread":"0.20"},{"groupId":"OG001","value":"0.37","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.11"},{"groupId":"OG001","value":"0.30","spread":"0.11"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.38","spread":"0.19"},{"groupId":"OG001","value":"0.37","spread":"0.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.07"},{"groupId":"OG001","value":"0.30","spread":"0.08"}]}]}]},{"type":"SECONDARY","title":"Child 17q21 Genotype","description":"Genotype at the rs12936231 SNP","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"93","spread":null},{"groupId":"OG001","value":"78","spread":null}]},{"measurements":[{"groupId":"OG000","value":"152","spread":null},{"groupId":"OG001","value":"161","spread":null}]},{"measurements":[{"groupId":"OG000","value":"66","spread":null},{"groupId":"OG001","value":"68","spread":null}]}]}]},{"type":"SECONDARY","title":"Fecal Microbiome Profile","description":"We extracted DNA and sequenced the bacterial 16S V4 hyper-variable region. The average number of 16S region reads sequenced per participant is provided here. Prior evidence suggests that read counts of at least 1,000 are adequate for 16S fecal microbiome profiling (Reference: Momozawa Y, et cal. Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One. 2011 Feb 10;6(2):e16952.)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10787","spread":"3534"},{"groupId":"OG001","value":"10773","spread":"2511"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13443","spread":"8624"},{"groupId":"OG001","value":"14024","spread":"9010"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11709","spread":"4202"},{"groupId":"OG001","value":"11635","spread":"3488"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12095","spread":"4733"},{"groupId":"OG001","value":"12407","spread":"4288"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0"},{"groupId":"OG001","value":"0","spread":"0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0"},{"groupId":"OG001","value":"0","spread":"0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0"},{"groupId":"OG001","value":"0","spread":"0"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":75,"n":440},"commonTop":[]}}}